Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Sacubitril/Valsartan (LCZ696) is an orally bioavailable, dual angiotensin II receptor and neprilysin inhibitor for the treatment of hypertension and heart failure.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 38.00 | |
5 mg | In stock | $ 61.00 | |
10 mg | In stock | $ 85.00 | |
25 mg | In stock | $ 126.00 | |
50 mg | In stock | $ 158.00 | |
100 mg | In stock | $ 198.00 | |
500 mg | In stock | $ 492.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 89.00 |
Description | Sacubitril/Valsartan (LCZ696) is an orally bioavailable, dual angiotensin II receptor and neprilysin inhibitor for the treatment of hypertension and heart failure. |
In vitro | LCZ696 is a single molecule that is comprised of molecular moieties of valsartan, an ARB, and AHU377, a neprilysin inhibitor (1:1 ratio)[1]. |
Synonyms | Sacubitril mixture with Valsartan, Valsartan, Sacubitril, LCZ696 |
Molecular Weight | 957.99 |
Formula | C48H55N6O8Na3.2.5H2O |
CAS No. | 936623-90-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 9 mg/mL (9.82 mM), Heating is recommended.
H2O: 92 mg/mL (100.4 mM)
DMSO: 28 mg/mL (30.6 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Sacubitril/Valsartan 936623-90-4 Apoptosis Endocrinology/Hormones Metabolism Neprilysin RAAS hypertension Angiotensin Receptor orally Sacubitril mixture with Valsartan Cluster of differentiation 10 angiotensin receptor-neprilysin NEP Neutral endopeptidase inhibit ARN LCZ-696 Valsartan CD10 heart Inhibitor Sacubitril LCZ 696 LCZ696 inhibitor